Autopsy report · NCT02198209

Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation

“Investigator decided not to move forward with study prior to study start date”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Cedars-Sinai Medical Center

Sponsor type

University, hospital or other

Conditions

Type 2 Diabetes

Interventions

Liraglutide

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• The Impact of E-liquid Nicotine Content on Reinforcement in Current Smokers
  “Study team decided not to move forward with study” (77% match in meaning)
• Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
  “Decision was made to not go forward with the study” (75% match in meaning)
• To Compare the Efficacy of I.V 200 mg Iron Sucrose and 500 mg Iron Sucrose to Treat Anemia in Pregnancy
  “The investigators decided not to proceed with this study” (75% match in meaning)
• Multiregion BHA in Open Tibia Fractures
  “study never started and is delayed until further notice” (73% match in meaning)
• Clearblue Advanced Fertility Monitor Consumer Three Cycle at Home Study
  “Study not started, no longer required” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.